Neurophase Therapeutics ApS

CVR 46458125 · Private limited company (ApS) · Active · Medium risk

Neurophase Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. CEO: Kristian Strømgaard, Kristian Kølby Kristensen, Vita Sereika-Bejder.

Bankruptcy risk for Neurophase Therapeutics ApS

1.9%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Number of CEOs3+ · bankruptcy rate 4.0%0.46×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46458125
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
c/o BII, Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 20k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOKristian StrømgaardCurrent
CEOKristian Kølby KristensenCurrent
CEOVita Sereika-BejderCurrent
Owner (20%)Kristian Kølby KristensenCurrent
Owner (20%)Vita Sereika-BejderCurrent
Owner (5%)Thi Kim Chi LeCurrent
Owner (5%)Jaroslava Kofoed SmolikovaCurrent
Owner (5%)Alberte Vad MathiesenCurrent
Owner (25%)KRISTIAN STRØMGAARD HOLDING ApSCurrent
FounderKristian Kølby KristensenCurrent
FounderVita Sereika-BejderCurrent
FounderThi Kim Chi LeCurrent
FounderJaroslava Kofoed SmolikovaCurrent
FounderAlberte Vad MathiesenCurrent
FounderKRISTIAN STRØMGAARD HOLDING ApSCurrent

The CEOs' other companies

Kristian Strømgaard – 5 other companies

Address history (0 moves)

c/o BII, Ole Maaløes Vej 3, 2200 København N

Other companies at the same address

Similar companies in København

Questions and answers about Neurophase Therapeutics ApS

Has Neurophase Therapeutics ApS gone bankrupt?

No, Neurophase Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Neurophase Therapeutics ApS?

Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Neurophase Therapeutics ApS?

Kristian Strømgaard, Kristian Kølby Kristensen, Vita Sereika-Bejder are the CEOs of Neurophase Therapeutics ApS.

When was Neurophase Therapeutics ApS founded?

Neurophase Therapeutics ApS was founded on 3 May 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.